Compare Enveric Biosciences Inc (ENVB) vs NOV Inc. Common Stock (NOV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs NOV Inc. Common Stock — how do they compare? Enveric Biosciences Inc trades at $1.51 (market cap $6.80M), while NOV Inc. Common Stock trades at $19 (market cap $6.77B). The key difference: NOV Inc. Common Stock is far larger — about 995.6× Enveric Biosciences Inc's market cap, and NOV Inc. Common Stock pays a 1.9% dividend while Enveric Biosciences Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Enveric Biosciences Inc for 14 Days and NOV Inc. Common Stock for 0 Days on average.
| ENVB | NOV | |
|---|---|---|
Market Cap | $6.80M | $6.77B |
Volume | 64,867 | 3,592,724 |
Sector | Health | Energy |
52-Week High | $10.80 | $21.71 |
52-Week Low | $1.27 | $12.31 |
Typical Hold Time | 14 Days | 0 Days |
Enterprise Value | -$1.49M | $7.93B |
Dividend Yield | — | 1.9% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ENVB trades at $1.495 with a 1.7% daily gain, showing technical bearish signals despite recent earnings beats. The company reported no revenue in 2025 with significant losses (-$8.77M net income), though valuation metrics appear low (EV/EBITDA 0.17, P/B 0.84). Recent news highlights patent approvals and positive preclinical data for non-hallucinogenic therapeutics.
The outlook remains speculative given the lack of revenue and substantial losses, offset by strong analyst support (75% buy rating) and promising drug development progress. Key risks include funding needs and clinical trial outcomes, while institutional sentiment appears cautiously optimistic about long-term pipeline potential.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About NOV Inc. Common Stock
NOV provides technology, equipment, and services for energy production. Its offerings support drilling, well construction, and production across oil, gas, renewables, and emerging energy markets.
Read more on NOV →
